HIV and AIDS Trial, Recruiting NCT05910268 Sponsor: Yale University Condition: HIV and AIDS
Back to Hiv Aids

HIV and AIDS Trial, Recruiting

NCT05910268
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For the Clinician Survey group:

  • People who currently work at a primary health care (PHC) or secondary health care (SHC) facility that is taking part in this study, and who agree to participate.

For the Continuing Professional Development group:

  • People who currently work as a nurse or doctor and have completed the required ECHO training program.

For the PHC Leadership Survey group:

  • People who are currently in a leadership role at a primary health care facility.

Who may not be able to join:

  • People who do not currently work at a participating primary or secondary health care facility (for the Clinician Survey group).
  • People who have not completed the required ECHO training (for the Continuing Professional Development group).
  • People who are not currently serving in a leadership role at a primary health care facility (for the PHC Leadership Survey group).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Frederick Altice, M.D., M.A., Yale University

Phone: 203-737-2883

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
1 April 2024
Est. completion
1 July 2028

Where this trial is recruiting

🇵🇪 Peru 🇺🇸 United States

Primary endpoints

Percentage of diagnosed PWH in treatment in PHC within the district

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov